Welcome to our dedicated page for Hancock Whitney Corporation news (Ticker: HWCPL), a resource for investors and traders seeking the latest updates and insights on Hancock Whitney Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Hancock Whitney Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Hancock Whitney Corporation's position in the market.
Hancock Whitney Corporation announced the redemption of all its 5.95% Subordinated Notes due 2045 (the "2045 Notes"), totaling $150 million, at 100% principal plus accrued interest. This will incur one-time costs of approximately $4.2 million included in Q2 2021 results. The company anticipates annualized cost savings of about $9 million and a positive impact of 5 basis points on the net interest margin (NIM). The 2045 Notes will no longer trade on the Nasdaq Stock Market.
